Patent: 10,226,595
Summary for Patent: 10,226,595
| Title: | Spring cannulae |
| Abstract: | Disclosed herein are embodiments of spring cannulae, including one or more holes in the sidewall of the cannula. Some disclosed cannulae include a wire, helically wound to form coils, and at least one hole in the cannula that interrupts one or more of the coils. Some embodiments further include a fused region of the coils through which the hole passes. Some embodiments include a ring attached to ends of the interrupted coils, where the hole is surrounded by the ring. Some embodiments include a sheath that is attached to a radial surface of the interrupted coils, where the hole passes radially though the sheath. Some embodiments include an elongated coil with a hole passing between the elongated coil and an adjacent coil. Further embodiments disclose cannulae that include a wire helically wound to form coils, and an insert having a porous section with at least one hole. |
| Inventor(s): | Manouchehr A. Miraki, Bryan Janish, Raymond J. McManus, Brent K. Hoffman |
| Assignee: | Edwards Lifesciences Corp |
| Application Number: | US15/107,404 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,226,595
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Csl Behring Gmbh | HAEGARDA | c1 esterase inhibitor subcutaneous (human) | For Injection | 125606 | June 22, 2017 | 10,226,595 | 2035-06-16 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,226,595
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 3154618 | ⤷ Start Trial |
| United States of America | 11141564 | ⤷ Start Trial |
| United States of America | 11806483 | ⤷ Start Trial |
| United States of America | 2017021127 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
